24 July 2023
Recordings from Drug Discovery & Development Symposium 2023 - Digital Health Technology and digital endpoints
Digital Health Technology (DHT) advancements & implementation at the FDA, Foundation for National Institutes of Health (FNIH) & pharma to optimise clinical trial designs & endpoints in PH
Chairs: Christine Garnett & Peter Fernandes
Panellists: Veronica Franco & Harry Rowland
FDA Center for Drug Evaluation & Research (CDER) Division of Cardiology & Nephrology (DCN)
Speaker: Christine Garnett
FNIH Initiative To Further The Clinical Outcome Assessment (COA) Development Of DHT Endpoints
Speakers: Josh Fessel & Jessilyn Dunn
FNIH, pharma & academia pioneering of digital endpoints
Taking the plunge with actigraphy: USA & China (lessons learnt)
Speaker: Peter Fernandes
Videos are uploaded across 5 pages:
- Page 1: Digital Health TEchnology (DHT) advancements & implementation at the FDA, Foundation for National Institutes of Health (FNIH) & Pharma to optimise clinical trial designs & endpoints in PH; and FNIH, Pharma & academia pioneering of digital endpoints
- Page 2: Novel trial designs: The decentralised trial design: overcoming the hidden obstacles
- Page 3: Lessons learnt from clinical trials in PH groups 3 & 3: What are the similarities & differences in pathogenesis & pathophysiology?
- Page 4: Novel drug & device therapies
- Page 5: Disruptive technologies in novel drug discovery
